Share

7th International Chronic Total Occlusion Summit in New York City

The Cardiovascular Research Foundation hosts scientific meeting on latest breakthroughs and techniques for improving success rate of chronic total occlusions

WHAT: The Seventh International Chronic Total Occlusion (CTO) Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions. This year's summit will include:

• Presentations from experts in the field
• Case review sessions
• Thematically organized live coronary CTO cases broadcast in high definition from Scripps Clinic and Research Foundation (La Jolla, CA) and Columbia University Medical Center (New York, NY)
• Essential techniques, tips, and information for determining how to treat CTOs

WHY: Chronic total occlusions of coronary arteries represent one of the greatest challenges to interventional cardiologists. Successful revascularization of CTOs has been strongly associated with improved left ventricular function, freedom from angina, a reduced risk of revascularization and in several studies increased survival. Through new guidewires, novel devices, appropriate patient selection, and improved operator technique, the success rate for recanalization of complex CTOs is increasing. The novel retrograde approach to CTOs has been introduced as an alternative route for recanalization of otherwise difficult or impossible lesions.

WHEN: February 4 – 5, 2010

WHERE: New York Marriott Marquis Hotel
New York, NY

For more information visit: http://www.ctosummit.org/home.html

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.

The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in the subspecialty of interventional cardiology and endovascular medicine.

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.